AdRegeneer exists to redefine neuroregeneration and restore hope for patients suffering from neurodegenerative diseases. We believe that regeneration is possible, and we are committed to developing innovative, patient-centric therapies that go beyond symptom management.
Some insights
Our team excels in neurodegenerative disease research, drug development, and regulatory strategy. We bring expertise in preclinical to clinical translational biotech business development. Moving forward, we aim to integrate expertise in commercialization and strategic partnerships.